External beam radiotherapy and high-dose brachytherapy combined with cisplatin and paclitaxel in patients with advanced cervical carcinoma

Gynecologic Oncology

Volumn 99, Issue 2, 2005, Pages 334-338

  Petera, Jiří ^a   Odrážka, Karel ^a   Frgala, Tomáš ^b   Špaček, Jiří ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^b MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

Cisplatin; External beam radiotherapy; Paclitaxel

Indexed keywords

CISPLATIN; HEMOGLOBIN; ONDANSETRON; PACLITAXEL;

ADULT; ADVANCED CANCER; ALLERGIC REACTION; ANEMIA; ARTICLE; BEAM THERAPY; BLADDER DISEASE; BLOOD TOXICITY; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HEMOGLOBIN DETERMINATION; HUMAN; LEUKOPENIA; MULTIMODALITY CANCER THERAPY; PARAAORTIC LYMPH NODE; PELVIS; PRIORITY JOURNAL; RADIATION DOSE; RECTUM DISEASE; SURVIVAL RATE; THROMBOCYTOPENIA; TOXICITY; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CISPLATIN; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC DISEASES; HUMANS; MIDDLE AGED; PACLITAXEL; RETROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 27144533252     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.06.015     Document Type: Article

References (17)

1. J.A. Green, J.M. Kirwan, and J.F. Tierney Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix Lancet 385 2001 781 786
2. M. Rodriguez, B.U. Sevin, J. Perras, H.N. Nguyen, C. Pham, and A.J. Steren Paclitaxel: a radiation sensitizer of human cervical cancer cells Gynecol. Oncol. 57 1995 165 169
3. H. Choy, W. Akerly, H. Safran, J. Clark, V. Rege, and A. Papa Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small cell lung cancer J. Clin. Oncol. 12 1994 2682 2686
4. W.P. McGuire, J.A. Blessing, D. Moore, S.S. Lentz, and G. Photopulos Paclitaxel has moderate activity in squamous cervix cancer: a Gynecologic Oncology Group study J. Clin. Oncol. 14 1996 792 795
5. M.D. Chen, P.J. Paley, R.A. Potish, and L.B. Twinggs Phase I trial of taxol as a radiation sensitizer with cisplatin in advanced cervical cancer Gynecol. Oncol. 67 1997 131 136
6. S. Pignata, P. Frezza, S. Tramontana, F. Perrone, R. Tambaro, and G. Casella Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri Ann. Oncol. 2000 455 459
7. L. Souhami, R. Seymour, T.N. Roman, G. Stanimir, M. Trudeau, and B.G. Clark Weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy in patients with locally advanced cancer of the cervix Int. J. Radiat. Oncol., Biol., Phys. 27 1993 871 878
8. H.G. Strauss, T. Kuhnt, C. Laban, D. Puschmann, S. Pigorsch, and J. Dunst Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy Strahlenther. Onkol. 178 2002 378 385
9. A. Cerrotta, G. Garden, R. Cavina, F. Raspagliesi, B. Stefanon, and I. Garassino Concurrent radiotherapy and weekly paclitaxel for locally advanced or recurrent squamous cell carcinoma of the uterine cervis. A study with intensification of dose Eur. J. Gynaecol. Oncol. 23 2002 115 119
10. F.Y. De Vos, A.M. Bos, J.A. Gieterna, E. Pras, A.G. Van der Zee, and E.G. De Vries Paclitaxel and carboplatin concurrent with radiotherapy for primary cervical cancer Anticancer Res. 24 2004 345 348
11. M. Rotman, T.F. Pajak, K. Choi, M. Clery, V. Marcial, and P.W. Grigsby Prophylactic extended field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten year treatment results of RTOG 79-20 J. Am. Med. Assoc. 274 1995 387 393
12. J.H. Malfetano, H. Keys, M.J. Cunningham, S. Gibbons, and R. Ambros Extended field radiation and cisplatin for stage IIB and IIIB cervical carcinoma Gynecol. Oncol. 67 1997 203 207
13. M.A. Varia, B.N. Bundy, G. Deppe, R. Mannel, H.E. Averette, and P.G. Rose Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a gynecologic oncology group study Int. J. Radiat. Oncol., Biol., Phys. 42 1998 1015 1023
14. W.A. Peters, P.Y. Liu, R.J. Barret, R.J. Stock, B.J. Monk, and J.S. Berek Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J. Clin. Oncol. 18 2000 1606 1613
15. M. Morris, P.J. Eifel, J. Lu, P.W. Grigsby, C. Levenback, and R.E. Stevens Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N. Engl. J. Med. 340 1999 1137 1143
16. A.J. Mundt, L.K. Mell, and J.C. Roeske Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy Int. J. Radiat. Oncol., Biol., Phys. 56 2003 1354 1364
17. A. Mayer, C. Nemeskéri, C. Petneházi, G. Borqgulya, S. Varga, and A. Naszály Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma, comparison of continuous versus sequential regimens Strahlenther. Onkol. 180 2004 209 2153